Article Details
Retrieved on: 2025-01-22 21:24:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company's intranasal foralumab, a fully human anti-CD3 monoclonal antibody, is currently in Phase 2 trials. The biomarker discoveries are ...
Article found on: www.stocktitan.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here